Reuters logo
BRIEF-Synairgen announces data update from clinical trial of inhaled interferon beta (SNG001) and clinical plan for COPD
September 27, 2017 / 6:21 AM / 3 months ago

BRIEF-Synairgen announces data update from clinical trial of inhaled interferon beta (SNG001) and clinical plan for COPD

Sept 27 (Reuters) - SYNAIRGEN PLC:

* DATA UPDATE AND CLINICAL PLAN FOR COPD

* DATA UPDATE FROM CLINICAL TRIAL OF INHALED INTERFERON BETA (SNG001) AND CLINICAL PLAN FOR COPD

* SIGNIFICANT POSITIVE FINDINGS IN PATIENTS WITH A CONFIRMED VIRAL INFECTION IN INEXAS TRIAL

* DESIGNED A SHORT TRIAL FOR WINTER OF 2017/18 TO EVALUATE POTENTIAL OF SNG001 IN COPD, WHICH IS BEING SUBMITTED FOR REGULATORY APPROVAL

* UNEXPECTEDLY LOW EXACERBATION RATE IN INEXAS TRIAL POPULATION SUGGESTS ECONOMIC VIABILITY OF DRUG IN ASTHMA INDICATION WOULD BE LIMITED Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below